{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:54:33Z","timestamp":1788346473082,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.transci.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T01:00:53Z","timestamp":1504141253000},"page":"661-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunoadsorption using Immusorba TR and PH"],"prefix":"10.1016","volume":"56","author":[{"given":"Ryuichiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2017.08.011_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1526-0968.2003.00010.x","volume":"7","author":"Hirata","year":"2003","journal-title":"Ther Apher Dial."},{"key":"10.1016\/j.transci.2017.08.011_bib0010","first-page":"318","article-title":"Efficiency and biocompatibility of new immunoadsorbent","volume":"28","author":"Yamazaki","year":"1982","journal-title":"Trans Am Soc Artif Intern Organs."},{"key":"10.1016\/j.transci.2017.08.011_bib0015","series-title":"Progress in Artificial Organs Cleveland","first-page":"719","article-title":"In vitro removal of anti-acetylcholine receptor antibodies with a new immunoadsorbent in sera from myasthenia gravis patients","author":"Sato","year":"1983"},{"key":"10.1016\/j.transci.2017.08.011_bib0020","first-page":"397","article-title":"Plasmapheresis for autoimmune neurological diseases","volume":"7","author":"Shibuya","year":"1990","journal-title":"Neurol Therapeutics."},{"key":"10.1016\/j.transci.2017.08.011_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1744-9987.1998.tb00126.x","article-title":"Elevated bradykinin and decreased carboxypeptidase R as a cause of hypotension during tryptophan column immunoadsorption therapy","volume":"2","author":"Tsuboi","year":"1998","journal-title":"Ther Apher."},{"key":"10.1016\/j.transci.2017.08.011_bib0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jnnp.57.5.578","article-title":"Immunoadsorption therapy for myasthenia gravis","volume":"57","author":"Shibuya","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.transci.2017.08.011_bib0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","article-title":"Treatment of myasthenia gravis by immunoadsorption of plasma","volume":"45","author":"Grob","year":"1995","journal-title":"Neurology."},{"key":"10.1016\/j.transci.2017.08.011_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000322497","article-title":"Early aggressive treatment strategy against myasthenia gravis","volume":"65","author":"Nagane","year":"2011","journal-title":"Eur Neurol."},{"key":"10.1016\/j.transci.2017.08.011_bib0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jca.20317","article-title":"A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis","volume":"26","author":"K\u00f6hler","year":"2011","journal-title":"J Clin Apher."},{"key":"10.1016\/j.transci.2017.08.011_bib0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1756285616637046","article-title":"Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration","volume":"9","author":"Schneider-Gold","year":"2016","journal-title":"Ther Adv Neurol Disord."},{"key":"10.1016\/j.transci.2017.08.011_bib0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0955-3886(93)90047-X","article-title":"Plasma exchange and selective adsorption in Guillain?Barre syndrome: a comparison of therapies by clinical course and side effects","volume":"14","author":"Rosenow","year":"1993","journal-title":"Transfus Sci."},{"key":"10.1016\/j.transci.2017.08.011_bib0060","first-page":"323","article-title":"Removal ability of IgG anti-GQ1b antibody in immunoadsorption therapy for Fisher syndrome: comparison of the removal ability between tryptophan column and phenylalanine column","volume":"36","author":"Ichikawa","year":"1996","journal-title":"Clin Neurol."},{"key":"10.1016\/j.transci.2017.08.011_bib0065","first-page":"565","article-title":"Plasmapheresis CIDP Neurol","volume":"12","author":"Sadamoto","year":"1995","journal-title":"Therapeutics"},{"key":"10.1016\/j.transci.2017.08.011_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000331011","article-title":"Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment","volume":"66","author":"Galldiks","year":"2011","journal-title":"Eur Neurol"},{"key":"10.1016\/j.transci.2017.08.011_bib0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000447059","article-title":"Escalation therapy of steroid refractory multiple sclerosis relapse with tryptophan immunoadsorption \u2013 Observational multicenter study with 147 patients","volume":"75","author":"Schimrigk","year":"2016","journal-title":"Eur Neurol."},{"key":"10.1016\/j.transci.2017.08.011_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosissup.2012.10.025","article-title":"Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients","volume":"14","author":"Heigl","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.transci.2017.08.011_bib0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12883-015-0377-2","article-title":"Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption","volume":"15","author":"De Masi","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.transci.2017.08.011_bib0090","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","article-title":"Treatment of progressive multifocal leukoencephalopathy associated with natalizumab","volume":"361","author":"Wenning","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.transci.2017.08.011_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jca.21324","article-title":"Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase","volume":"30","author":"Kobayashi","year":"2015","journal-title":"J Clin Apher."},{"key":"10.1016\/j.transci.2017.08.011_bib0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1744-9987.12347","article-title":"Efficacy of tryptophan immunoadsorption plasmapheresis for neuromyelitis optica in two cases","volume":"19","author":"Yasuda","year":"2015","journal-title":"Ther Apher Dial."},{"key":"10.1016\/j.transci.2017.08.011_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1756285616646332","article-title":"Immunoadsorption in patients with neuromyelitis optica spectrum disorder","volume":"9","author":"Faissner","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.transci.2017.08.011_bib0110","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00415-016-8277-y","article-title":"Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study","volume":"263","author":"Heine","year":"2016","journal-title":"J Neurol."},{"key":"10.1016\/j.transci.2017.08.011_bib0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ene.12389","article-title":"Tryptophan immunoadsorption for the treatment of autoimmune encephalitis","volume":"22","author":"K\u00f6hler","year":"2015","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.transci.2017.08.011_bib0120","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1212\/NXI.0000000000000207","article-title":"Immunoadsorption therapy in autoimmune encephalitides","volume":"3","author":"Dogan Onugoren","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.transci.2017.08.011_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0033-1333873","article-title":"Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report","volume":"44","author":"Yonee","year":"2013","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.transci.2017.08.011_bib0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2169\/naika.75.362","article-title":"Comparison of therapeutic plasma exchange and hydrophobic amino acid adsorbent therapy in management of rheumatoid arthritis","volume":"75","author":"Takahashi","year":"1986","journal-title":"Nihon Naika Gakkai Zasshi."},{"key":"10.1016\/j.transci.2017.08.011_bib0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.transci.2010.10.003","article-title":"Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis","volume":"43","author":"Loo","year":"2010","journal-title":"Transfus Apher Sci."}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T03:26:15Z","timestamp":1535426775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050217301623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1473050217301623"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2017.08.011","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoadsorption using Immusorba TR and PH","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}